The Melanocortin Signal System of the Hypothalamus and Its Functional State in Type 2 Diabetes Mellitus and Metabolic Syndrome A. O. ShpakovK. V. Derkach OriginalPaper 17 May 2017 Pages: 495 - 507
Mechanisms of Neuron Loss in Alzheimer’s Disease V. N. MukhinK. I. PavlovV. M. Klimenko OriginalPaper 16 May 2017 Pages: 508 - 516
Changes in Nociceptive Thresholds and Adenylyl Cyclase System Activity in Skeletal Muscles in Rats with Acute and Mild Type 1 Diabetes V. N. ShipilovA. M. TrostA. O. Shpakov OriginalPaper 16 May 2017 Pages: 517 - 523
Effects of Cold Stress on the Functional Activity of Mouse Peritoneal Macrophages in Conditions of Opiate Receptor Blockade S. V. GeinI. L. Sharav’eva OriginalPaper 16 May 2017 Pages: 524 - 527
The Mobility of AMPA-Type Glutamate Receptors as a Key Factor in the Expression and Maintenance of Synaptic Potentiation T. A. ZaparaA. L. ProskuraA. S. Ratushnyak OriginalPaper 16 May 2017 Pages: 528 - 533
Current Concepts of the Intrathecal Humoral Immune Response and the Diagnostic Significance of the Detection of Oligoclonal Immunoglobulins in Multiple Sclerosis G. S. MakshakovS. V. LapinE. P. Evdoshenko OriginalPaper 16 May 2017 Pages: 534 - 539
Potential of Positron Emission Tomography for Studies of the Mechanisms of Development of Multiple Sclerosis (published data and authors’ results) I. D. StolyarovA. M. PetrovL. N. Prakhova OriginalPaper 16 May 2017 Pages: 540 - 543
Multiple Sclerosis Disease-Modifying Drugs in Children and Adolescents O. V. BykovaI. A. NankinaA. N. Boiko OriginalPaper 17 May 2017 Pages: 544 - 552
Treatment with Ex Vivo Expanded Autologous Regulatory CD4+CD25+Foxp3+CD127low T Cells Restores the Balance of the Immune System in Patients with Remitting Multiple Sclerosis D. D. EliseevaG. V. LifshitsS. N. Bykovskaya OriginalPaper 17 May 2017 Pages: 553 - 560
Comparison of the Results of Using β-Interferon-1a Formulations 30 μg for Intramuscular Administration and β-Interferon-1a 44 μg for Subcutaneous Injections in Daily Clinical Practice for the Treatment of Multiple Sclerosis O. G. BoretsN. F. GovorukhinaA. N. Boiko OriginalPaper 17 May 2017 Pages: 561 - 564
Results of an Open Prospective Trial of β-Interferon Bioanalogs D. S. KasatkinN. N. SpirinN. S. Baranova OriginalPaper 16 May 2017 Pages: 565 - 569
The Potential of Music Therapy in Neurology Using Multiple Sclerosis as an Example E. A. BoikoE. V. IvanchukT. T. Batysheva OriginalPaper 16 May 2017 Pages: 570 - 572
GABA Receptors in the Modulation of Fear Memory Extinction N. I. Dubrovina OriginalPaper 16 May 2017 Pages: 573 - 584
Microtubule Motor Proteins and the Mechanisms of Synaptic Plasticity N. A. Vasil’evaA. S. Pivovarov OriginalPaper 16 May 2017 Pages: 585 - 594
Local Protein Synthesis in Dendritic Terminals and Its Regulation in Normal Conditions and during Plastic Changes E. A. ChesnokovaP. M. Kolosov OriginalPaper 16 May 2017 Pages: 595 - 607
Morphometric Evaluation of the Neuroprotective Action of an Extract of Astragalus Membranaceous in the Brains of Rats during Restraint Stress S. M. GulyaevL. N. ShantanovaE. T. Batotsyrenova OriginalPaper 16 May 2017 Pages: 608 - 611